[Federal Register Volume 64, Number 43 (Friday, March 5, 1999)]
[Notices]
[Pages 10667-10668]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-5412]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of General Medical Sciences; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel, Pharmacology.
Date: March 26, 1999.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
[[Page 10668]]
Place: National Institutes of Health, NIGMS, Office of
Scientific Review, Natcher Building, Room 1AS-13, Bethesda, MD
20892, (Telephone Conference Call).
Contact Person: Irene B. Glowinski, PhD., Scientific Review
Administrator, Office of Scientific Review, National Institute of
General Medical Sciences, National Institutes of Health, Natcher
Building, Room 1AS-13, Bethesda, MD 20892, (301) 594-3663.
(Catalogue of Federal Domestic Assistance Program Nos. 93.375,
Minority Biomedical Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology, Physiology, and
Biological Chemistry Research; 93.862, Genetics and Developmental
Biology Research; 93.88, Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National Institutes of Health, HHS)
Dated: February 26, 1999.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 99-5412 Filed 3-4-99; 8:45 am]
BILLING CODE 4140-01-M
